Reduction of anti-inflammatory drug costs with newer aspirin formulations

Anti-inflammatory/analgesic drugs account for a large proportion of prescriptions and prescribing costs, particularly for ambulatory patients. Although aspirin is highly effective, 95% of anti-inflammatory/analgesic prescriptions have been for the newer, more expensive alternatives. Recently two new...

Full description

Saved in:
Bibliographic Details
Published inMedical care Vol. 23; no. 8; p. 998
Main Authors Hershey, C O, Brown, A, Porter, D K
Format Journal Article
LanguageEnglish
Published United States 01.08.1985
Subjects
Anti-Inflammatory Agents, Non-Steroidal
Arthritis, Rheumatoid - drug therapy
Aspirin
Cost Control
Drug Utilization - economics
Humans
Ohio
Pharmacy Service, Hospital - economics
Ohio
Online AccessGet more information

Cover

More Information
Summary:Anti-inflammatory/analgesic drugs account for a large proportion of prescriptions and prescribing costs, particularly for ambulatory patients. Although aspirin is highly effective, 95% of anti-inflammatory/analgesic prescriptions have been for the newer, more expensive alternatives. Recently two newer aspirin formulations were made available on our hospital's formulary. Subsequently aspirin prescribing rose from 5% to 14.5% (P less than 0.0005), and mean pharmacy costs for anti-inflammatory analgesics fell 5.9% over a 7-month period (P less than 0.025). This decline in costs interrupted a historic trend toward increased prescription costs and was accomplished with minimal effort or hospital resources. Increased availability and familiarity with these newer aspirin formulations may substantially reduce costs for the health care system.
ISSN:0025-7079
DOI:10.1097/00005650-198508000-00007